Eyenovia regains Nasdaq minimum bid compliance after reverse stock split

HYPERION DEFI, INC.

Nasdaq notified Eyenovia on Feb 25, 2025 that it regained compliance with the $1.00 minimum bid requirement as of Feb 20.
Company had faced delisting after bid price fell below $0.10 for 10 consecutive days in Dec 2024.
Compliance achieved through a reverse stock split effective Jan 31, 2025, as disclosed in prior 8-K.
Nasdaq originally granted exception until Feb 14, 2025; stock will continue trading on Nasdaq Capital Market.
Bid price cure period initially ran to March 17, 2025, but was superseded by low-priced stock rule.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.